drugset / Trial / NCT01081353

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

NCT01081353

Phase 1 Completed 26 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

To determine the bioequivalence of new formula of aspirin relative to the established commercial effervescent aspirin when taken orally by healthy adult subjects

Timeline

Start
2010-02
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral

Indications

No indication recorded.